WLMs included several drugs given FDA approval for short-term and long-term use, like semaglutide 2.4 mg (Wegovy, Novo Nordisk), liraglutide, phentermine and benzphetamine. Patients’ use of WLMs ...

John W. Ostrominski, M.D., from Brigham and Women's Hospital in Boston, and colleagues describe trends in insurance claims for GLMs and WLMs after tirzepatide approval in a population-based cohort ...

“Research efforts evaluating the evolving trends in utilization of GLMs and WLMs are critical to inform patients and providers, evaluate and forecast shifts in clinical practice, and enhance ...

Use of semaglutide 2.0 mg and semaglutide 2.4 mg rose from 38% to 46% and 0% to 32%, respectively. Use of all other WLMs decreased during the same period. Among incident users, by the end of 2023, ...

Hence, this cohort study investigated the trends in the utilization of glucose-lowering medications (GLMs) and weight-lowering medications (WLMs) after regulatory approval of tirzepatide in the United ...

We've identified the following companies as similar to null because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the ...

We've identified the following companies as similar to null because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the ...

Find more information on the Altmetric Attention Score and how the score is calculated. Wormlike micelles (WLMs) are highly sensitive to alkanes, resulting in structural destruction and loss of ...

"The deployment of ARG and WLMS technologies in Carmona City underscores our commitment to enhancing weather monitoring capabilities and fortifying disaster preparedness, prevention, and mitigation ...